It is a chemicals private limited company based in Lucknow, Uttar Pradesh, India, established in 2022.
2022 | Lucknow, Uttar Pradesh, India | ActiveIndic Regen Pharmaceuticals Private Limited, a active private limited company, was established on 31 March 2022 in Lucknow, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24290UP2022PTC161655. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.
Its leadership includes Alok Kumar Pandey (Director), Amit Kumar Pandey (Director), Saurabh Gupta (Director). Past directors included Afroz Sher Khan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No.103, Presidency Tower Omega Green Park Township, Chinhat, Lucknow, Uttar Pradesh, 226028.
U24290UP2022PTC161655
161655
31 March 2022
₹1.50 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Indic Regen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Alok Kumar Pandey | Director | 31 Mar 2022 | Current |
| Amit Kumar Pandey | Director | 31 Mar 2022 | Current |
| Saurabh Gupta | Director | 31 Mar 2022 | Current |
| Ashutosh Dwivedi | Director | 31 Mar 2022 | Current |
| Pushpa Mishra | Director | 07 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Jul 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Indic Regen Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Indic Regen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Indic Regen Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Indic Regen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indic Regen Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pushpa Mishra was appointed as a Director was appointed as a Director on 07 Jul 2025 & has been associated with this company since 4 months 28 days . was completed.
Progress on Indic Regen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Indic Regen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
The activity Alok Kumar Pandey was appointed as a Director was appointed as a Director on 31 Mar 2022 & has been associated with this company since 3 years 8 months . was completed.
Progress on Amit Kumar Pandey was appointed as a Director was appointed as a Director on 31 Mar 2022 & has been associated with this company since 3 years 8 months . was documented.
Progress on Saurabh Gupta was appointed as a Director was appointed as a Director on 31 Mar 2022 & has been associated with this company since 3 years 8 months . was documented.
The CIN of Indic Regen Pharmaceuticals Private Limited is U24290UP2022PTC161655.
Indic Regen Pharmaceuticals Private Limited is headquartered at Flat No.103, Presidency Tower Omega Green Park Township, Chinhat, Lucknow, Uttar Pradesh, 226028.
Indic Regen Pharmaceuticals Private Limited was incorporated on 31 March 2022.
The current directors of Indic Regen Pharmaceuticals Private Limited are
The primary industry of Indic Regen Pharmaceuticals Private Limited is Chemicals.
Indic Regen Pharmaceuticals Private Limited is unlisted.
The authorized capital of Indic Regen Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX